Stay tuned for the 2021 edition!


Information about the 2021 speakers will be announced soon!

Learn from industry experts and influencers about the latest topics and solutions for challenges faced by the Latin American biotech and life science sector.


Over the years, BIO Latin America has featured amazing speakers from around the world and from all key sectors of the life sciences industry, who have made our conference successful by sharing with our delegates their insights and knowledge.

The Program and Speakers of the 2021 edition will be available soon. Meanwhile, to give you a taste of what’s coming, take a look at the 2019 Program and 2019 Speakers and see below a list of a few speakers of past editions:


Some of our past editions speakers:


  • Andreas Baumann, Director for Global Early Development, Bayer
  • Andrew Robertson, Director for US Regulatory Policy, Merck & Co
  • Andreas Baumann, Director for Global Early Development, Bayer
  • Andrew Robertson, Director for US Regulatory Policy, Merck & Co
  • Eduardo Calderari, Market Access, Governmental Affairs & Commercial Head, Roche
  • Hadyn Parry, CEO, Oxitec
  • Heraldo Marchezini, CEO, Biomm
  • Hubert Guarino, General Manager for Brazil, Sanofi Pasteur
  • João Sanches, Government Affairs & Corporate Communications Head, Novartis
  • Juan Conde, General Manager for Brazil, Baxalta
  • Katherine Tsokas, Global Regulatory Affairs, Head of Regenerative Medicine & Advanced Therapy, Janssen Research & Development
  • Marcela Silvino, Head, Sanofi Genzyme Brazil
  • Marcello Scattolini, Access & Government Affairs Director, Boehringer Ingelheim
  • María Eugenia Sánchez, Regional Director Clinical Ops Latin America, Lilly
  • Maria Paula Marques, VP for Regulatory and Scientific Affairs, Allergan
  • Marité Prieto, Regulatory Affairs, Safety and Compliance Director, Amgen
  • Norton Oliveira, Senior Vice President & Head of Latin America, Alnylam Pharmaceuticals
  • Om Arora, Latin America Regional Head, Pfizer
  • Paulo Castilho, Innovation Coordinator, Natura
  • Patrick Kilbride, Senior Vice President, The Global Innovation Policy Center
  • Rogerio Ribeiro, SVP Emerging Markets, GSK
  • Rogerio Vivaldi, CEO, Sigilon Therapeutics
  • Sridhar Gopal, International Head of Business Development, AbbVie
  • Tom Luby, Head of JLABS @ Texas Medical Center, Johnson & Johnson Innovation


  • Alan Vanderborght, CEO, Kybora Emerging Markets
  • Andrew Callaway, Managing Director, Healthcare Investment Banking / Deutsche Bank
  • Fernando Reinach, Managing Partner, Fundo Pitanga
  • Fred Aslan, Vice President, Venrock Associates
  • Gabriela Cezar, CEO & Principal Partner, Panarea Partners
  • Guilherme Emrich, Founder, FirCapital
  • Guillaume Sagez, Managing Partner, Performa Investimentos
  • Jayme Queiroz, Investment Officer, Apex-Brasil
  • Mark Wilson, Principal, Strategic Technology Bioconsulting / Healthcare Specialist, Global Corporate Venturing
  • Paulo Braga, Head of Corporate Venture, Eurofarma
  • Roel Collier, Principal, TPG ART
  • Thomas Gerlach, Director, BBI Financial


  • Achilles Zaluar Neto, Ambassador, Director of the Department for Technology Promotion, Ministry of Foreign Affairs (Brazil)
  • Carolina da Silva, Coordinator of the Biotechnology Sector Council, Ministry of Industry, Energy and Mining (Uruguay)
  • Dámaso Pardo, President, INPI (Argentina)
  • Diego Olivera, Secretary General, National Drug Board / President, Institute for Regulation and Control of Cannabis (Uruguay)
  • Evelyne Rodríguez, Minister for Latin America, ProMéxico (Mexico)
  • Jimena Morales, Director, General Health Council (Mexico)
  • João Paulo Pieroni, Head of the Health Complex Department, BNDES (Brazil)
  • Lino Barañao, Minister, Ministry for Science, Technology & Innovative Production (Argentina)
  • Luiz Otávio Pimentel, President, INPI (Brazil)
  • Marcelo Morales, Secretary of Policies for Training and Strategic Actions, Ministry of Science, Technology, Innovations and Communications (Brazil)
  • Marco Antonio Fireman, Secretary of Science, Technology and Strategic Inputs, Brazilian Ministry of Health (Brazil)
  • Rafael Moreira, Secretary of Innovation and New Business, Brazilian Ministry of Industry, Foreign Trade and Services (Brazil)
  • Renato Porto, Director, ANVISA (Brazil)


  • Bob Blouin, Dean, University of North Carolina, Eshelman School of Pharmacy
  • Carlos Gil Ferreira, Coordinator of Clinical Research, Brazilian National Cancer Institute
  • Claudio Terra, Director of Innovation & Knowledge Management, Hospital Albert Einstein
  • Dimas Tadeu Covas, Director, Instituto Butantan
  • Eliseu de Oliveira, Program Scientific Manager of the National Cancer Institute – Chemical Biology Consortium, Georgetown University
  • Elizabeth de Carvalhaes, President, Interfarma
  • Grega Kumer, Head of Government Relations, IFPMA
  • Juan Carlos Trujillo, International Policy Director, FIFARMA
  • Luiz Fernando Reis, Research Superintend, Hospital Sírio-Libanês
  • Marco Krieger, Vice President of Production and Innovation in Health, Fiocruz
  • Mark Crowell, Founding Executive Director of UVA Innovation, University of Virginia Innovation
  • Mike Pieck, Small Business Program Coordinator, SBIR/STTR, National Institutes of Health (NIH)
  • Rodrigo Correa, VP of Research and Biological Collections, Fiocruz
  • Xavier Soberón, General Director, INMEGEN (Mexico)



Save your spot for 2021!

More information about the next edition will be announced soon. Click here to join the waiting list and guarantee a special discount for your early registration!